John Moore
Vermögen: 414 995 $ am 30.06.2026
Vermögen: 414 995 $ am 30.06.2026
John R.
Moore is General Counsel at Edgewise Therapeutics, Inc. since 2020.
Formerly, Mr. Moore was Independent Director at Nivalis Therapeutics, Inc. from 2012 to 2017, Secretary & General Counsel at Peloton Therapeutics, Inc. from 2018 to 2019, Counsel at Instil Bio, Inc. in 2020, Secretary, Vice President & General Counsel at Array BioPharma, Inc. from 2002 to 2017, Senior Vice President-Human Resources at Calpine LLC, Attorney at Wilson Sonsini Goodrich & Rosati PC from 1999 to 2002, Attorney at Arnold White & Durkee Corp.
from 1996 to 1999, and Attorney at Kenyon & Kenyon LLP from 1992 to 1996.
Education includes an undergraduate degree from The University of North Carolina at Chapel Hill in 1986, a graduate degree from the University of Illinois At Urbana–Champaign in 1989, and a doctorate from UNC School of Law in 1992.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.08.2025 | 10’214 ( 0.01% ) | 414 995 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | General Counsel | 01.09.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| INSTIL BIO, INC. | Corporate Officer/Principal | 01.12.2020 |
| PELOTON THERAPEUTICS, INC. | General Counsel | 01.09.2019 |
| ARRAY TECHNOLOGIES, INC. | General Counsel | 01.09.2017 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Direktor/Vorstandsmitglied | 01.07.2017 |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2002 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Calpine Corp.
Calpine Corp. Electric UtilitiesUtilities Generates and supplies electricity from natural gas & geothermal resources | Utilities |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Arnold White & Durkee Corp.
Arnold White & Durkee Corp. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenyon & Kenyon LLP
Kenyon & Kenyon LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
UNC School of Law
UNC School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen